<?php

/*
|--------------------------------------------------------------------------
| Editorial content for "X vs Y" comparison pages
|--------------------------------------------------------------------------
| Keyed "slugA__slugB" (order-insensitive lookup in the controller). Adds an
| intro, a "which should you choose" verdict, and a FAQ to the existing
| side-by-side comparison at /peptides/compare/{a}/vs/{b}. Both peptide slugs
| must exist & be published. These pairs also drive the sitemap.
|
| Educational only — verdicts reflect the research, not a recommendation to use.
*/

return [

    'tirzepatide__semaglutide' => [
        'intro' => 'Tirzepatide and semaglutide are the two most-studied weight-management peptides, but they are not the same class. Semaglutide is a single GLP-1 receptor agonist; tirzepatide is a dual GIP/GLP-1 agonist, which is why it tends to produce greater average weight loss in trials.',
        'verdict' => 'In head-to-head and indirect trial comparisons, tirzepatide shows larger average weight reduction (~20%+ at higher doses) than semaglutide (~15%). Semaglutide has the longer real-world safety record and more flexible dosing. Choose tirzepatide for maximal effect in the research; semaglutide for the deepest evidence base.',
        'faqs' => [
            ['q' => 'Is tirzepatide better than semaglutide for weight loss?', 'a' => 'In trials, tirzepatide produced greater average weight loss (roughly 20%+ vs ~15%), largely because it activates both GIP and GLP-1 receptors. Semaglutide has more long-term data. “Better” depends on tolerability and goals.'],
            ['q' => 'What is the main difference between tirzepatide and semaglutide?', 'a' => 'Semaglutide targets one receptor (GLP-1); tirzepatide targets two (GIP and GLP-1). The dual mechanism is the main reason tirzepatide shows stronger appetite and weight effects in research.'],
            ['q' => 'Do tirzepatide and semaglutide have the same side effects?', 'a' => 'Both share the GLP-1-class gastrointestinal effects (nausea, etc.), which are managed by titrating the dose up slowly. Individual tolerability varies.'],
        ],
    ],

    'retatrutide__tirzepatide' => [
        'intro' => 'Retatrutide and tirzepatide represent the cutting edge of incretin research. Tirzepatide is a dual GIP/GLP-1 agonist already widely studied; retatrutide adds a third target — the glucagon receptor — making it a triple agonist with the highest weight-loss figures reported so far, but far less long-term data.',
        'verdict' => 'Retatrutide has posted higher average weight loss than tirzepatide in early trials, thanks to its triple-agonist mechanism. But tirzepatide has vastly more clinical and real-world evidence. Choose tirzepatide for the proven track record; retatrutide is the higher-ceiling, earlier-stage research compound.',
        'faqs' => [
            ['q' => 'Is retatrutide stronger than tirzepatide?', 'a' => 'Early trials suggest retatrutide produces greater average weight loss, because it adds glucagon-receptor activity on top of GIP/GLP-1. However, it is earlier in development with less safety data than tirzepatide.'],
            ['q' => 'What makes retatrutide a “triple agonist”?', 'a' => 'It activates three receptors — GLP-1, GIP and glucagon — whereas tirzepatide activates two. The added glucagon activity is thought to increase energy expenditure.'],
        ],
    ],

    'semaglutide__cagrilintide' => [
        'intro' => 'Semaglutide (a GLP-1 agonist) and cagrilintide (a long-acting amylin analogue) work through complementary appetite pathways, which is why they are studied together as “CagriSema” rather than as direct rivals.',
        'verdict' => 'These are usually combined, not chosen between — cagrilintide adds amylin-driven satiety on top of semaglutide’s GLP-1 effect, and the combination has shown greater weight loss than either alone in research. On its own, semaglutide has far more standalone data.',
        'faqs' => [
            ['q' => 'Are semaglutide and cagrilintide used together?', 'a' => 'Yes — the “CagriSema” research combines them because they target different satiety pathways (GLP-1 and amylin), producing additive appetite suppression.'],
            ['q' => 'What does cagrilintide add to semaglutide?', 'a' => 'Cagrilintide is an amylin analogue that slows gastric emptying and increases fullness through a separate mechanism, complementing semaglutide’s GLP-1 effect.'],
        ],
    ],

    'bpc-157__tb-500' => [
        'intro' => 'BPC-157 and TB-500 are the two pillars of peptide recovery research, and they are most often studied together rather than as alternatives. BPC-157 is associated with localized tendon, ligament and gut repair; TB-500 (a thymosin beta-4 fragment) with systemic cell migration and flexibility.',
        'verdict' => 'For most recovery research the two are combined — the “systemic repair stack” — because their mechanisms complement each other. If choosing one: BPC-157 for localized/gut injuries, TB-500 for broader, systemic tissue repair.',
        'faqs' => [
            ['q' => 'Should I use BPC-157 or TB-500?', 'a' => 'They are usually researched together as a stack because BPC-157 targets localized repair (tendon, gut) while TB-500 supports systemic cell migration. For a single compound, match it to whether the target is local or systemic.'],
            ['q' => 'Can you stack BPC-157 and TB-500?', 'a' => 'Yes — this is one of the most common recovery stacks. Use the protocol tool to plan reconstitution, dose and timing for both at once.'],
            ['q' => 'What is the difference between BPC-157 and TB-500?', 'a' => 'BPC-157 is a gastric-derived peptide studied for localized healing and angiogenesis; TB-500 is a synthetic thymosin beta-4 fragment studied for systemic cell migration and flexibility.'],
        ],
    ],

    'bpc-157__thymosin-beta-4' => [
        'intro' => 'BPC-157 and thymosin beta-4 (TB-4, the parent peptide of TB-500) are both central to tissue-repair research but act differently — BPC-157 on localized healing and angiogenesis, TB-4 on actin regulation, cell migration and reduced scarring.',
        'verdict' => 'Like BPC-157 and TB-500, these are complementary rather than competing. TB-4 is the full parent peptide; TB-500 is its commonly used fragment. BPC-157 remains the localized-repair specialist of the pair.',
        'faqs' => [
            ['q' => 'What is the difference between TB-500 and thymosin beta-4?', 'a' => 'Thymosin beta-4 is the full naturally occurring peptide; TB-500 is a synthetic fragment of it commonly used in research. Their effects overlap, with TB-500 being the more widely studied form.'],
        ],
    ],

    'cjc-1295__sermorelin' => [
        'intro' => 'CJC-1295 and sermorelin are both growth-hormone-releasing hormone (GHRH) analogues — they prompt the pituitary to release the body’s own GH. The key difference is duration: sermorelin is short-acting, while CJC-1295 (especially with DAC) lasts far longer.',
        'verdict' => 'Sermorelin gives a short, natural GH pulse and clears quickly; CJC-1295 sustains elevated GH-releasing signal for much longer, meaning fewer injections. Choose sermorelin for a closer-to-physiological pulse, CJC-1295 for convenience and a stronger sustained effect.',
        'faqs' => [
            ['q' => 'Is CJC-1295 better than sermorelin?', 'a' => 'CJC-1295 lasts much longer than sermorelin, so it needs fewer injections and sustains a higher GH-releasing signal. Sermorelin produces a shorter, more natural pulse. Neither is universally “better” — it depends on the research goal.'],
            ['q' => 'What is the difference between CJC-1295 and sermorelin?', 'a' => 'Both are GHRH analogues, but sermorelin is short-acting while CJC-1295 (particularly the DAC version) is long-acting, extending the GH-release window dramatically.'],
        ],
    ],

    'mk-677__ipamorelin' => [
        'intro' => 'MK-677 (ibutamoren) and ipamorelin are both growth-hormone secretagogues that work on the ghrelin receptor — but MK-677 is an orally active small molecule with a long half-life, while ipamorelin is an injectable peptide with a short, clean pulse.',
        'verdict' => 'Ipamorelin gives a short, selective GH pulse with minimal effect on cortisol or appetite; MK-677 sustains elevated GH/IGF-1 around the clock from a daily oral dose (and can increase appetite). Choose ipamorelin for pulsatile, injection-based research; MK-677 for sustained, needle-free convenience.',
        'faqs' => [
            ['q' => 'Is MK-677 or ipamorelin better?', 'a' => 'MK-677 is oral and keeps GH/IGF-1 elevated continuously; ipamorelin is injectable and produces a short, clean pulse. MK-677 is more convenient but can raise appetite; ipamorelin is more selective.'],
            ['q' => 'Is MK-677 a peptide?', 'a' => 'No — MK-677 (ibutamoren) is a non-peptide small molecule that mimics ghrelin. Ipamorelin is a true peptide. Both stimulate GH release.'],
        ],
    ],

    'ipamorelin__sermorelin' => [
        'intro' => 'Ipamorelin and sermorelin both boost growth hormone but through different receptors — ipamorelin is a ghrelin/GH-secretagogue, sermorelin is a GHRH analogue. They are frequently combined because the two pathways amplify each other.',
        'verdict' => 'They are complementary: sermorelin (GHRH) raises the release signal while ipamorelin (ghrelin agonist) triggers the pulse. Used together they produce a stronger, more natural GH release than either alone.',
        'faqs' => [
            ['q' => 'Can you stack ipamorelin and sermorelin?', 'a' => 'Yes — combining a GHRH analogue (sermorelin) with a GH secretagogue (ipamorelin) produces a synergistic GH release, which is why they are often researched together.'],
        ],
    ],

    'selank__semax' => [
        'intro' => 'Selank and Semax are the two best-known Russian nootropic peptides, often used as a pair. Semax leans toward focus, memory and BDNF; Selank leans toward calm, reduced anxiety and balanced mood — without sedation.',
        'verdict' => 'Choose Semax for stimulation, focus and cognitive drive; Selank for anxiety reduction and calm focus. Many research protocols use both — Semax for daytime focus, Selank to take the edge off.',
        'faqs' => [
            ['q' => 'What is the difference between Semax and Selank?', 'a' => 'Semax is more stimulating and focus-oriented (raising BDNF and dopamine tone); Selank is more calming and anxiolytic. They are complementary and often used together.'],
            ['q' => 'Can you use Semax and Selank together?', 'a' => 'Yes — a common nootropic pairing uses Semax for focus and Selank for calm, balancing stimulation with anxiety reduction.'],
        ],
    ],

    'ghk-cu__ahk-cu' => [
        'intro' => 'GHK-Cu and AHK-Cu are both copper tripeptides used in skin and hair research, but they specialize differently — GHK-Cu is the broad skin-remodelling and wound-repair peptide, while AHK-Cu is studied more for hair follicle stimulation.',
        'verdict' => 'Choose GHK-Cu for skin: collagen, elasticity and wound repair have the strongest data. Choose AHK-Cu when the target is hair growth. They are sometimes combined in topical research formulas.',
        'faqs' => [
            ['q' => 'What is the difference between GHK-Cu and AHK-Cu?', 'a' => 'GHK-Cu is the broad skin-repair and collagen copper peptide; AHK-Cu is researched more specifically for hair follicle stimulation. Both are copper tripeptides used topically.'],
        ],
    ],

    'mots-c__nad-plus' => [
        'intro' => 'MOTS-c and NAD+ are both staples of metabolic and longevity research, but they act at different points. MOTS-c is a mitochondrial-derived peptide that signals metabolic adaptation; NAD+ is a coenzyme central to energy production and DNA repair.',
        'verdict' => 'They are complementary longevity tools — NAD+ fuels the cellular machinery while MOTS-c signals it to adapt. For raw cellular energy and repair, NAD+; for metabolic/exercise-mimetic signalling, MOTS-c.',
        'faqs' => [
            ['q' => 'Should I use MOTS-c or NAD+?', 'a' => 'They target different parts of metabolism — NAD+ is a coenzyme for energy and DNA repair, MOTS-c is a signalling peptide for metabolic adaptation. They are often researched together rather than as alternatives.'],
        ],
    ],

    'pt-141__melanotan-ii' => [
        'intro' => 'PT-141 (bremelanotide) and Melanotan II are both melanocortin-system peptides, which is why they share some effects. Melanotan II was developed for pigmentation (tanning) but was noted to affect arousal; PT-141 is the refined version developed specifically for sexual desire, without the tanning effect.',
        'verdict' => 'Choose PT-141 for libido/arousal research — it is the targeted, FDA-approved (as Vyleesi) melanocortin agonist. Choose Melanotan II for pigmentation research. PT-141 avoids the skin-darkening that Melanotan II causes.',
        'faqs' => [
            ['q' => 'What is the difference between PT-141 and Melanotan II?', 'a' => 'Both act on the melanocortin system, but Melanotan II is primarily a tanning peptide that also affects arousal, while PT-141 was refined specifically for sexual desire and does not cause tanning.'],
        ],
    ],

    'tesamorelin__cjc-1295' => [
        'intro' => 'Tesamorelin and CJC-1295 are both GHRH analogues that raise growth hormone and IGF-1. Tesamorelin has the deepest clinical data (studied for visceral fat reduction); CJC-1295 (with DAC) is prized for its long duration and convenience.',
        'verdict' => 'Choose tesamorelin for the strongest clinical evidence and visceral-fat research; CJC-1295-DAC for long-lasting GH elevation with fewer injections. Both are frequently paired with a ghrelin agonist like ipamorelin.',
        'faqs' => [
            ['q' => 'Is tesamorelin or CJC-1295 better?', 'a' => 'Tesamorelin has more clinical data (notably for visceral fat); CJC-1295-DAC lasts longer per injection. Both are GHRH analogues and are often paired with ipamorelin.'],
        ],
    ],

    'hgh__mk-677' => [
        'intro' => 'HGH (recombinant growth hormone) and MK-677 (ibutamoren) both raise GH activity, but by opposite routes. HGH is exogenous growth hormone itself; MK-677 is an oral secretagogue that prompts your own pituitary to release more GH.',
        'verdict' => 'HGH delivers growth hormone directly and potently but bypasses the body’s feedback loop; MK-677 raises your own GH/IGF-1 more gently and orally. Choose HGH for direct, maximal effect; MK-677 for a needle-free, feedback-preserving approach.',
        'faqs' => [
            ['q' => 'Is MK-677 the same as HGH?', 'a' => 'No. HGH is growth hormone itself; MK-677 stimulates your own pituitary to release more GH. MK-677 is oral and works with the body’s feedback system, while HGH is injected and acts directly.'],
        ],
    ],

];
